Summit Global Investments’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-20,609
Closed -$630K – 493
2024
Q4
$630K Buy
+20,609
New +$580K 0.04% 311

Other funds holding GH

Summit Global Investments's GH Position: Q1 2025 in Review

Summit Global Investments sold out of Guardant Health (GH) in Q1 2025, closing a stake of 20,609 shares — an estimated $630K sold.

Summit Global Investments first reported a position in GH in Q4 2024 and held it in 1 quarter. The position peaked at $630K in Q4 2024. 342 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Summit Global Investments reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Summit Global Investments sold 20,609 Guardant Health shares in Q1 2025, an estimated $630K.
  • Summit Global Investments first reported a position in Guardant Health in Q4 2024 and held it in 1 quarter.
  • Summit Global Investments's Guardant Health position peaked at $630K in Q4 2024.
  • 342 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Summit Global Investments's 13F filing for Q1 2025, filed 7 Apr 2025.